The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine
- PMID: 16377384
- DOI: 10.1053/j.ajkd.2005.09.029
The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine
Abstract
Background: Oxidative stress is related to endothelial dysfunction (ED) and cardiovascular outcomes in patients with chronic kidney disease. Increased asymmetric dimethylarginine (ADMA) levels are among the main causes of ED. We aim to investigate any association between ED and ADMA levels, as well as levels of oxidative stress markers, in patients with chronic kidney disease.
Methods: One hundred fifty-nine patients without diabetes with chronic kidney disease were studied. Staging was performed according to glomerular filtration rate, determined as stages 1 to 5 according to the Kidney Disease Outcomes Quality Initiative (n = 30, 33, 28, 32, and 36, respectively). The control group consisted of 30 healthy subjects. Oxidative stress markers (plasma malondialdehyde [MDA], erythrocyte superoxide dismutase [SOD], glutathione peroxidase [GSH-Px]), trace elements (erythrocyte zinc [EZn], erythrocyte copper [ECu]), plasma selenium (Se), and serum ADMA were studied. Brachial artery endothelium-dependent vasodilatation (FMD) was calculated for all.
Results: FMD, SOD, GSH-Px, EZn, ECu, and Se values were lower, whereas MDA and ADMA levels were higher in patients than controls. Glomerular filtration rate correlated negatively with MDA and ADMA levels and positively with FMD, SOD, and GSH-Px values. These parameters were significantly different among patients with stages 2, 3, 4, and 5 (hemodialysis group; P < 0.001 for all). Regression analysis showed that ADMA (beta = -0.228; P < 0.01), SOD (beta = 0.405; P < 0.001), and oxidized low-density lipoprotein levels (beta = -0.428; P < 0.001) were related independently to FMD, whereas glomerular filtration rate was not involved in the model.
Conclusion: The present results imply that FMD, oxidative stress, and ADMA levels all are associated with stage of chronic kidney disease. Additionally, levels of oxidative stress markers and ADMA independently determine endothelial function.
Comment in
-
Multiple mechanisms for abnormal selenium levels and vascular disease in renal failure.Am J Kidney Dis. 2006 May;47(5):924; author reply 924-5. doi: 10.1053/j.ajkd.2006.02.187. Am J Kidney Dis. 2006. PMID: 16632036 No abstract available.
Similar articles
-
Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens.Am J Nephrol. 2005 May-Jun;25(3):250-5. doi: 10.1159/000086079. Epub 2005 May 27. Am J Nephrol. 2005. PMID: 15925859
-
The Effect of Corrected Inflammation, Oxidative Stress and Endothelial Dysfunction on Fmd Levels in Patients with Selected Chronic Diseases: A Quasi-Experimental Study.Sci Rep. 2020 Jun 2;10(1):9018. doi: 10.1038/s41598-020-65528-6. Sci Rep. 2020. PMID: 32488098 Free PMC article. Clinical Trial.
-
Copper/zinc and copper/selenium ratios, and oxidative stress as biochemical markers in recurrent aphthous stomatitis.J Trace Elem Med Biol. 2013 Oct;27(4):312-6. doi: 10.1016/j.jtemb.2013.04.002. Epub 2013 Apr 12. J Trace Elem Med Biol. 2013. PMID: 23664921
-
Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review.Acta Biochim Pol. 2006;53(4):663-77. Epub 2006 Dec 11. Acta Biochim Pol. 2006. PMID: 17160142 Review.
-
Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.Clin Exp Nephrol. 2007 Jun;11(2):115-121. doi: 10.1007/s10157-007-0471-x. Epub 2007 Jun 28. Clin Exp Nephrol. 2007. PMID: 17593510 Review.
Cited by
-
Mitochondrial Reactive Oxygen Species and Their Contribution in Chronic Kidney Disease Progression Through Oxidative Stress.Front Physiol. 2021 Apr 23;12:627837. doi: 10.3389/fphys.2021.627837. eCollection 2021. Front Physiol. 2021. PMID: 33967820 Free PMC article. Review.
-
Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.BMC Nephrol. 2010 Apr 27;11:7. doi: 10.1186/1471-2369-11-7. BMC Nephrol. 2010. PMID: 20423474 Free PMC article.
-
Vitamin E in renal therapeutic regiments.Pediatr Nephrol. 2006 Dec;21(12):1790-801. doi: 10.1007/s00467-006-0211-6. Epub 2006 Sep 21. Pediatr Nephrol. 2006. PMID: 17186590 Review.
-
Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.J Am Soc Nephrol. 2015 Apr;26(4):935-44. doi: 10.1681/ASN.2013121355. Epub 2014 Aug 22. J Am Soc Nephrol. 2015. PMID: 25150156 Free PMC article.
-
FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability.Am J Physiol Endocrinol Metab. 2014 Sep 1;307(5):E426-36. doi: 10.1152/ajpendo.00264.2014. Epub 2014 Jul 22. Am J Physiol Endocrinol Metab. 2014. PMID: 25053401 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical